Saxenda may harm your unborn baby Before taking Saxenda , tell your health care provider about all of your medical conditions, including if you: have any of the conditions listed in the section What is the most important information I should know about Saxenda ? are taking certain medications called GLP-1 receptor agonists are allergic to liraglutide or any of the other ingredients in Saxenda have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food have or have had problems with your pancreas, kidneys or liver have or have had depression or suicidal thoughts are pregnant or plan to become pregnant
7 AveryJ
Australia GLP-1 Receptor Agonist Market Size Analysis Market Size (USD Million): 2024: $499.12M 2025: $570.49M 2026: $652.07M 2027: $745.32M 2028: $851.90M 2029: $973.72M 2030: $1,112.97M 2031: $1,272.12M 2032: $1,454.03M 2033: $1,661.96M 2034: $1,899.62M CAGR: 14.30% 2025-34 Australia GLP-1 Receptor Agonist Market Key Drivers and Challenges: Key Market Drivers: Rising Demand for Effective Metabolic Therapies: The growing rates of type 2 diabetes and obesity in Australia are creating a surge in demand for GLP-1 receptor agonists
Koal, T., Klavins, K., Seppi, D., Kemmler, G
Procedures like gastric sleeve or gastric bypass physically limit food intake and alter gut hormone signaling, producing effects such as: Reduced appetite Improved insulin sensitivity Favorable changes in metabolism that help sustain long-term weight loss Additional Benefits of Surgery : 2035% average total body weight loss (some patients achieve 50% or more) High rates of remission or significant improvement in: Type 2 diabetes High blood pressure Sleep apnea High cholesterol Long-term cost savings compared to decades of prescription medication A one-time procedure with durable, decades-long results when combined with healthy habits Side-by-Side Comparison To help you see the differences at a glance, heres how GLP-1 medications stack up against bariatric surgery in the real world: GLP-1 Medications Still Have a Role While the study shows bariatric surgery typically delivers greater and longer-lasting results, GLP-1s remain an important tool in certain scenarios: For patients who dont qualify for surgery (BMI under 35 without comorbidities) For those who arent medically cleared for anesthesia or major surgery As a first step before surgery for patients who prefer a less invasive approach Before surgery to reduce liver size and surgical risks After surgery to help maintain results for those who experience weight regain years later How to Decide: GLP-1s or Surgery
doi:10.1016/j.isci.2020.101116
